difusion
-
Regulatory
DiFusion Inc. Announces FDA 510K Clearance for Xiphos™ ZFUZE™
November 04, 2019 AUSTIN, Texas–(BUSINESS WIRE)–DiFusion, Inc. today announced the FDA 510K clearance for the Xiphos-ZF Spinal interbody device. Xiphos-ZF…
Read More » -
DiFusion’s CleanFuze™ Antimicrobial Polymer Receives European Clearance
GEORGETOWN, Texas, Feb. 25, 2014 /PRNewswire/ — DiFusion Incorporated announced today that the company has received a CE Mark and European clearance…
Read More » -
Spine
DiFusion gets $5.2M of planned $16M funding
Medical device maker DiFusion Inc. has received $5.2 million of a planned $16 million financing. The Georgetown-based company collected the…
Read More » -
DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
AUSTIN, Texas–(BUSINESS WIRE)–DiFUSION Technologies is a medical device company focused on the development and commercialization of its proprietary CleanFUZE™ anti-microbial…
Read More » -
DiFUSION Technologies Receives 510(k) Clearance of Xiphos™ Interbody Implants for Spinal Fusion
AUSTIN, Texas–(BUSINESS WIRE)–DiFUSION Technologies Inc., a medical device company focused on the development and commercialization of its proprietary CleanFUZE™ anti-microbial…
Read More » -
DiFUSION Technologies Adds Accomplished Senior Management Team
AUSTIN, Texas–(BUSINESS WIRE)–DiFUSION Technologies, Inc. announced today the company has reached another major milestone with the addition of talented industry…
Read More »